Oncology Trials

  • 30/05/2023

    A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers

    View Trial
  • 31/03/2029

    RAIDER

    A Randomised phase II trial of Adaptive Image guided standard or Dose Escalated tumour boost Radiotherapy in the treatment of transitional cell carcinoma of the bladder

    View Trial
  • 24/01/2025

    Pacific 4

    A Phase III Randomized Placebo-controlled Double-blind Multi-center International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)

    View Trial
  • 01/01/2024

    ATHENA

    A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

    View Trial
  • 31/12/2020

    BRITER

    Brain Imaging to predict Toxicity in Elderly patients after Radiotherapy

    View Trial
  • 31/03/2024

    ROAM Trial

    Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial (The ROAM trial)

    View Trial
  • 28/02/2021

    PARADIGM

    Short-course radiotherapy plus olaparib for newly diagnosed glioblastoma in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose escalation study

    View Trial
  • 31/03/2021

    CamBMT1

    Cambridge Brain Mets Trial 1: A proof-of-principle phase 1b/ randomised phase 2 study of afatinib penetration into cerebral metastases for patients undergoing neurosurgical resection both with and without prior low-dose targeted radiotherapy

    View Trial
  • 31/08/2022

    SARON

    Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer. A randomised phase III trial.

    View Trial
  • 05/09/2016

    REQUITE

    Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors

    View Trial